[1] |
Hu H,Shu M,He L,et al.Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer[J].Br J Cancer,2017,116(5):658-668.
|
[2] |
Titus AJ,Gallimore RM,Salas LA.Cell-type deconvolution from DNA methylation:a review of recent applications[J].Hum Mol Genet,2017,26(R2):R216-R224.
|
[3] |
Cicchini L,Blumhagen RZ,Westrich JA,et al.High-risk human papillomavirus E7 alters host DNA methylome and represses HLA-E expression in human keratinocytes[J].Sci Rep,2017,7(1):3633.
|
[4] |
Choufani S,Cytrynbaum C,Chung BH,et al.NSD1 mutations generate a genome-wide DNA methylation signature[J].Nat Commun,2015,6:10 207.
|
[5] |
Sen P,Ganguly P,Ganguly N.Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer[J].Onco Lett,2018,15(1):11-22.
|
[6] |
Amaro-Filho SM,Chaves CBP,Felix SP,et al.HPV DNA methylation at the early promoter and E1/E2 integrity:a comparison between HPV16 HPV18 and HPV45 in cervical cancer[J].Papillomavirus Res,2018,5:172-179.
|
[7] |
Carestiato FN,Amaro-Filho SM,Moreira MAM.Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state:a comparison between cervical pre-neoplastic and neoplastic samples[J].Mem Inst Oswaldo Cruz,2018,114:e180456.
|
[8] |
Nan LP,Wang F,Ran D,et al.Naringin alleviates H2O2-induced apoptosis via the PI3K/Akt pathway in rat nucleus pulposus-derived mesenchymal stem cells[J].Connect Tissue Res,2019.doi:10.1080/03008207.2019.1631299.[Epub ahead of print]
|
[9] |
Bossler F,Hoppe-Seyler K,Hoppe-Seyler F.PI3K/AKT/mTOR signaling regulates the virus/host cell crosstalk in HPV-positive cervical cancer cells[J].Int J Mol Sci,2019,20(9):pii:E2188.
|
[10] |
Gupta S,Kumar P,Das BC.HPV:Molecular pathways and targets[J].Curr Probl Cancer,2018,42(2):161-174.
|
[11] |
Bossler F,Kuhn BJ,Günther T,et al.Repression of human papillomavirus oncogene expression under hypoxia is mediated by PI3K/mTORC2/AKT signaling[J].mBio,2019,10(1):e02323-18.
|
[12] |
Pim D,Massimi P,Dilworth SM,et al.Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A[J].Oncogene,2005,24(53):7830-7838.
|
[13] |
Mu?oz JP,Carrillo-Beltrán D,Aedo-Aguilera V,et al.Tobacco exposure enhances human papillomavirus 16 oncogene expression via EGFR/PI3K/Akt/c-Jun signaling pathway in cervical cancer cells[J].Front Microbiol,2018,9:3022.
|
[29] |
O′Donnell,Jake S,Massi D,Teng MWL,et al.PI3K-AKTmTOR inhibition in cancer immunotherapy,redux[J].Semin Cancer Biol,2018,48,91-103.
|
[14] |
Zhou BP,Liao Y,Xia W,et al.HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation[J].Nat Cell Biol,2001,3(11):973-982.
|
[15] |
Wang Y,Liu L,Chen Z.Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing[J].Artificial Cells,2019,47(1):2820-2829.
|
[16] |
Lee CY,Yang SF,Wang PH,et al.Antimetastatic effects of Terminalia catappa leaf extracts on cervical cancer through the inhibition of matrix metalloprotein-9 and MAPK pathway[J].Environ Toxicol,2019,34(1):60-66.
|
[17] |
Folgueras AR,Pendas AM,Sanchez LM,et al.Matrix metalloproteinases in cancer:from new functions to improved inhibition strategies[J].Int J Dev Biol,2004,48(5-6):411-424.
|
[18] |
Wang H,Zhang X,Huang L,et al.Matrix metalloproteinase-14 expression and its prognostic value in cervical carcinoma[J].Cell Biochem Biophys,2014,70(2):729-734.
|
[19] |
Matheus ER,Zonta MA,Discacciati MG,et al.MMP-9 expression increases according to the grade of squamous intraepithelial lesion in cervical smears[J].Diagn Cytopathol,2014,42(10):827-833.
|
[20] |
Hung CY,Lee CH,Chiou HL,et al.Praeruptorin-B inhibits 12-O-tetradecanoylphorbol-13-acetate-induced cell invasion by targeting AKT/NF-κB via matrix metalloproteinase-2/-9 expression in human cervical cancer cells[J].Cell Physiol Biochem,2019,52(6):1255-1266.
|
[21] |
Zanotta N,Tornesello ML,Annunziata C,et al.Candidate soluble immune mediators in young women with high-risk human papilloma-virus infection:high expression of chemokines promoting angiogenesis and cell proliferation[J].PLoS One,2016,11(3):e0151851.
|
[22] |
Cho YS,Kang JW,Cho MC,et al.Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18[J].FEBS Lett,2001,501(2-3):139-145.
|
[23] |
Tavares MC,de Lima Júnior SF,Coelho AV,et al.Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes polymorphisms are correlated with susceptibility to HPV infection in patients with and without cervical intraepithelial lesion[J].Ann Hum Biol,2016,43(4):261-268.
|
[24] |
Wentzensen N,Schiffman M,Palmer T,et al.Triage of HPV positive women in cervical cancer screening[J].Lancet Oncol,2016,76(2):S49-S55.
|
[25] |
Jiang H,Liang M,Jiang Y,et al.The lncRNA TDRG1 promotes cell proliferation,migration and invasion by targeting miR-326 to regulate MAPK1 expression in cervical cancer[J].Cancer Cell Int,2019,19:152.
|
[26] |
Schmitt A,Harry JB,Rapp B,et al.Comparison of the properties of the E6 and E7 genes of low-and high-risk cutaneous papillomaviruses reveals strongly transforming and high Rb-binding activity for the E7 protein of the low-risk human papillomavirus type 1[J].J Virol,1994,68(11):7051-7059.
|
[27] |
Bui N,Huang JK,Bojorquezgomez A,et al.Disruption of NSD1in head and neck cancer promotes favorable chemotherapeutic responses linked to hypomethylation[J].Mol Cancer Ther,2018,17(7):1585-1594.
|
[28] |
Hoppe-Seyler K,Bossler F,Braun JA,et al.The HPV E6/E7 oncogenes:key factors for viral carcinogenesis and therapeutic targets[J].Trends Microbiol,2018,26(2),158-168.
|